Published in Br J Cancer on October 07, 2002
Collagen density promotes mammary tumor initiation and progression. BMC Med (2008) 5.13
Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med (2008) 4.81
Breast tissue composition and susceptibility to breast cancer. J Natl Cancer Inst (2010) 3.39
Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res (2008) 3.05
Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res (2003) 2.37
Alternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across species. Am J Pathol (2010) 1.65
Positive association between mammographic breast density and bone mineral density in the Postmenopausal Estrogen/Progestin Interventions Study. Breast Cancer Res (2005) 1.39
Correlation of umbilical cord blood hormones and growth factors with stem cell potential: implications for the prenatal origin of breast cancer hypothesis. Breast Cancer Res (2007) 1.35
Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study. Breast Cancer Res (2007) 1.20
Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer. Ann Epidemiol (2012) 1.16
Physical activity, body mass index, and mammographic density in postmenopausal breast cancer survivors. J Clin Oncol (2007) 1.13
Sex steroids, growth factors and mammographic density: a cross-sectional study of UK postmenopausal Caucasian and Afro-Caribbean women. Breast Cancer Res (2009) 1.10
No relationship between circulating levels of sex steroids and mammographic breast density: the Prospect-EPIC cohort. Breast Cancer Res (2007) 1.07
Mammographic density and breast cancer after ductal carcinoma in situ. J Natl Cancer Inst (2004) 1.07
Prolactin and estrogen enhance the activity of activating protein 1 in breast cancer cells: role of extracellularly regulated kinase 1/2-mediated signals to c-fos. Mol Endocrinol (2005) 1.06
Mammographic density and epithelial histopathologic markers. BMC Cancer (2009) 1.00
Associations between endogenous sex hormone levels and mammographic and bone densities in premenopausal women. Cancer Causes Control (2009) 0.98
Circulating sex hormones and mammographic breast density among postmenopausal women. Horm Cancer (2011) 0.98
Mammographic density and hormone receptor expression in breast cancer: the Multiethnic Cohort Study. Cancer Epidemiol (2011) 0.97
Pre-diagnosis physical activity and mammographic density in breast cancer survivors. Breast Cancer Res Treat (2005) 0.96
Mammographic density and risk of breast cancer by adiposity: an analysis of four case-control studies. Int J Cancer (2011) 0.95
Active, but not passive cigarette smoking was inversely associated with mammographic density. Cancer Causes Control (2010) 0.95
Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density. BMC Med Genomics (2010) 0.95
Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer. Breast Cancer Res (2007) 0.95
Multiple kinase cascades mediate prolactin signals to activating protein-1 in breast cancer cells. Mol Endocrinol (2004) 0.94
Breast density and polymorphisms in genes coding for CYP1A2 and COMT: the Multiethnic Cohort. BMC Cancer (2007) 0.94
Adiposity, adult weight gain and mammographic breast density in US Chinese women. Int J Cancer (2010) 0.93
Obstetric history and mammographic density: a population-based cross-sectional study in Spain (DDM-Spain). Breast Cancer Res Treat (2012) 0.92
Metabolic syndrome and mammographic density: the Study of Women's Health Across the Nation. Int J Cancer (2011) 0.92
Height, adiposity and body fat distribution and breast density in young women. Breast Cancer Res (2012) 0.92
Cytochrome P450 1A2 (CYP1A2) activity, mammographic density, and oxidative stress: a cross-sectional study. Breast Cancer Res (2004) 0.92
Menstrual cycle-related fluctuations in breast density measured by using three-dimensional MR imaging. Radiology (2011) 0.92
Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, growth hormone, and mammographic density in the Nurses' Health Studies. Breast Cancer Res Treat (2012) 0.89
Estrogen metabolism and mammographic density in postmenopausal women: a cross-sectional study. Cancer Epidemiol Biomarkers Prev (2012) 0.89
Prolactin serum levels and breast cancer: relationships with risk factors and tumour characteristics among pre- and postmenopausal women in a population-based case-control study from Poland. Br J Cancer (2010) 0.89
Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study II. Breast Cancer Res (2012) 0.88
Breast cancer susceptibility loci and mammographic density. Breast Cancer Res (2008) 0.88
The vitamin D pathway and mammographic breast density among postmenopausal women. Breast Cancer Res Treat (2011) 0.88
Does equol production determine soy endocrine effects? Eur J Nutr (2012) 0.87
Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer. Breast Cancer Res (2010) 0.87
IGF gene polymorphisms and breast cancer in African-American and Hispanic women. Int J Oncol (2011) 0.86
Associations of physical activity, sedentary time, and insulin with percent breast density in Hispanic women. J Womens Health (Larchmt) (2007) 0.86
Relationship between breast cancer risk factors and mammographic breast density in the Fernald Community Cohort. Br J Cancer (2012) 0.86
Dense and nondense mammographic area and risk of breast cancer by age and tumor characteristics. Cancer Epidemiol Biomarkers Prev (2015) 0.85
Epidemiologic studies of isoflavones & mammographic density. Nutrients (2010) 0.84
Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease. Breast Cancer Res (2016) 0.84
Intact and total insulin-like growth factor-binding protein-3 (IGFBP-3) levels in relation to breast cancer risk factors: a cross-sectional study. Breast Cancer Res (2008) 0.84
Combined effects of endogenous sex hormone levels and mammographic density on postmenopausal breast cancer risk: results from the Breakthrough Generations Study. Br J Cancer (2014) 0.83
Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study. Breast Cancer Res (2004) 0.82
Effects of childhood body size on breast cancer tumour characteristics. Breast Cancer Res (2010) 0.82
IGF1, IGFBP1, and IGFBP3 genes and mammographic density: the Multiethnic Cohort. Int J Cancer (2010) 0.81
Parenchymal texture analysis in digital mammography: robust texture feature identification and equivalence across devices. J Med Imaging (Bellingham) (2015) 0.81
Physical activity and mammographic density in a cohort of postmenopausal Norwegian women; a cross-sectional study. Springerplus (2012) 0.80
Cyclic endogenous estrogen and progesterone vary by mammographic density phenotypes in premenopausal women. Eur J Cancer Prev (2016) 0.79
Adolescent endogenous sex hormones and breast density in early adulthood. Breast Cancer Res (2015) 0.79
Plasma levels of leptin and mammographic density among postmenopausal women: a cross-sectional study. Breast Cancer Res (2006) 0.79
Consumption of sweet foods and mammographic breast density: a cross-sectional study. BMC Public Health (2014) 0.78
Correlation of endogenous hormonal levels, fibroglandular tissue volume and percent density measured using 3D MRI during one menstrual cycle. Ann Oncol (2013) 0.78
Relationship of serum estrogens and metabolites with area and volume mammographic densities. Horm Cancer (2015) 0.77
The insulin-like growth factor system and its receptors: A potential novel anticancer target. Biologics (2008) 0.76
Prolactin signaling through focal adhesion complexes is amplified by stiff extracellular matrices in breast cancer cells. Oncotarget (2016) 0.76
Urinary cadmium and mammographic density in premenopausal women. Breast Cancer Res Treat (2011) 0.76
Immunoassay and Nb2 lymphoma bioassay prolactin levels and mammographic density in premenopausal and postmenopausal women the Nurses' Health Studies. Breast Cancer Res Treat (2014) 0.76
Variation in inflammatory cytokine/growth-factor genes and mammographic density in premenopausal women aged 50-55. PLoS One (2013) 0.76
Glycemic index, glycemic load and mammographic breast density: the EPIC Florence longitudinal study. PLoS One (2013) 0.76
Exogenous estrogen as mediator of racial differences in bioactive insulin-like growth factor-I levels among postmenopausal women. J Gerontol A Biol Sci Med Sci (2014) 0.75
The association of alcohol consumption with mammographic density in a multiethnic urban population. BMC Cancer (2015) 0.75
No evidence for association of inherited variation in genes involved in mitosis and percent mammographic density. Breast Cancer Res (2012) 0.75
Similarity of fibroglandular breast tissue content measured from magnetic resonance and mammographic images and by a mathematical algorithm. Int J Breast Cancer (2014) 0.75
Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells. Breast Cancer Res (2017) 0.75
Prenatal modulation of breast density and breast stem cells by insulin-like growth factor-1. Am J Stem Cells (2012) 0.75
A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density. Breast Cancer Res (2015) 0.75
Stromal characteristics may hold the key to mammographic density: the evidence to date. Oncotarget (2016) 0.75
Associations of Serum Levels of Sex Hormones in Follicular and Luteal Phases of the Menstrual Cycle with Breast Tissue Characteristics in Young Women. PLoS One (2016) 0.75
Mammographic breast density and tolerance for short-term postmenopausal hormone therapy suspension. J Womens Health (Larchmt) (2010) 0.75
Endogenous sex hormones and breast density in young women. Cancer Epidemiol Biomarkers Prev (2014) 0.75
Bioavailable insulin-like growth factor-I inversely related to weight gain in postmenopausal women regardless of exogenous estrogen. Cancer Epidemiol Biomarkers Prev (2013) 0.75
Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet (1998) 10.11
The quantitative analysis of mammographic densities. Phys Med Biol (1994) 5.71
Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst (1995) 5.35
Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev (1998) 4.71
A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst (1995) 4.29
Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA (2001) 2.45
Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group. Ann Intern Med (1999) 2.43
X-ray characterisation of normal and neoplastic breast tissues. Phys Med Biol (1987) 2.39
Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomarkers Prev (2001) 2.35
Insulin-like growth factors and cancer. Br J Cancer (1992) 2.31
Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res (2000) 2.10
Symmetry of projection in the quantitative analysis of mammographic images. Eur J Cancer Prev (1996) 2.00
Automated analysis of mammographic densities. Phys Med Biol (1996) 1.74
Tamoxifen and mammographic breast densities. Cancer Epidemiol Biomarkers Prev (2000) 1.72
Mammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen. Cancer Epidemiol Biomarkers Prev (1999) 1.72
Growth hormone treatment induces mammary gland hyperplasia in aging primates. Nat Med (1997) 1.67
Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst (1999) 1.46
Effect of tamoxifen on mammographic density. Cancer Epidemiol Biomarkers Prev (2000) 1.44
Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients. J Natl Cancer Inst (1990) 1.34
Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group. Metabolism (1997) 1.27
Serum steroid binding proteins and the bioavailability of estradiol in relation to breast diseases. J Natl Cancer Inst (1985) 1.13
Factors associated with mammographic pattern. Br J Radiol (1985) 1.12
A versatile method for the determination of serum cortisol binding globulin and sex hormone binding globulin binding capacities. Clin Chim Acta (1983) 1.10
Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels. Am J Obstet Gynecol (1977) 1.09
Mammographic breast density during hormone replacement therapy: differences according to treatment. Am J Obstet Gynecol (1999) 1.07
The relation of mammographic features of the breast to breast cancer risk factors. Am J Epidemiol (1982) 1.07
Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and prevention. Breast Cancer Res Treat (1998) 1.06
The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk: a population study of postmenopausal women. Eur J Cancer Clin Oncol (1988) 1.05
Augmentation of prolactin secretion by estrogen in hypogonadal women. J Clin Invest (1974) 1.03
A longitudinal study of the relationship of plasma somatomedin-C concentration to the pubertal growth spurt. Am J Dis Child (1987) 1.03
Breast cancer risk associated with reproductive factors and breast parenchymal patterns. J Natl Cancer Inst (1984) 1.00
Effects of growth hormone overexpression and growth hormone resistance on neuroendocrine and reproductive functions in transgenic and knock-out mice. Proc Soc Exp Biol Med (1999) 0.98
The insulin-like growth factors, their receptors, and their binding proteins in human breast cancer. Cancer Treat Res (1991) 0.96
Age and race related changes in mammographic parenchymal patterns. Cancer (1989) 0.94
Regulation of production and secretion of sex hormone-binding globulin in HepG2 cell cultures by hormones and growth factors. J Clin Endocrinol Metab (1995) 0.94
High frequency of mammary adenocarcinomas in metallothionein promoter-human growth hormone transgenic mice created from two different strains of mice. J Steroid Biochem Mol Biol (1992) 0.92
Intact and amino-terminally shortened forms of insulin-like growth factor I induce mammary gland differentiation and development. Proc Natl Acad Sci U S A (1992) 0.92
Regulation of sex hormone-binding globulin production by growth factors. Metabolism (1990) 0.91
Determinants of circulating insulin-like growth factor-I. J Endocrinol Invest (1999) 0.91
The role of growth hormone/insulin-like growth factors in adipocyte differentiation. Metabolism (1995) 0.91
The insulin-like growth factors and breast cancer--revisited. Breast Cancer Res Treat (1998) 0.89
Gender differences in secretory activity of the human somatotropic (growth hormone) axis. Eur J Endocrinol (1996) 0.89
Estradiol induction of cAMP in breast cancer cells is mediated by foetal calf serum (FCS) and sex hormone-binding globulin (SHBG). J Steroid Biochem Mol Biol (1999) 0.86
Effect of natural menopause on serum levels of IGF-I and IGF-binding proteins: relationship with bone mineral density and lipid metabolism in perimenopausal women. Eur J Endocrinol (1997) 0.85
Role of estrogen in the dopaminergic control of prolactin secretion. Endocrinology (1981) 0.85
Insulin-like growth factors: biochemistry and physiology. Baillieres Clin Endocrinol Metab (1991) 0.83
Direct effects of tamoxifen on growth hormone secretion by pituitary cells in vitro. Eur J Cancer (1992) 0.81
Weight regulation, leptin and growth hormone. Horm Res (1997) 0.81
The effect in post-menopausal women of natural human and artificial oestrogens on the concentration in serum of prolactin. Acta Endocrinol (Copenh) (1980) 0.80
Serum levels of growth hormone-binding protein and insulin-like growth factor-I during puberty. Clin Endocrinol (Oxf) (1992) 0.80
Interactive regulation of postmenopausal growth hormone insulin-like growth factor axis by estrogen and growth hormone-releasing peptide-2. Endocrine (2001) 0.79
The role of prolactin in the menopause. Maturitas (1994) 0.79
The role of prolactin in breast cancer. Recent Results Cancer Res (1976) 0.79
Stimulatory effect of 2-hydroxyestradiol on prolactin release in hypogonadal women. J Clin Endocrinol Metab (1980) 0.78
Spiral organisms in endoscopic biopsies of the human stomach. J Clin Pathol (1984) 8.46
Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med (1995) 7.88
A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet (1997) 7.15
Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA (1999) 6.05
The quantitative analysis of mammographic densities. Phys Med Biol (1994) 5.71
Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol Cell Biol (1987) 5.67
Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery: A randomized controlled trial. JAMA (2001) 4.30
Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci U S A (1996) 4.16
Global genetic structure and molecular epidemiology of encapsulated Haemophilus influenzae. Rev Infect Dis (1990) 4.06
The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr (1998) 3.96
Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med (1992) 3.71
Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol (1995) 3.66
Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc Natl Acad Sci U S A (1990) 3.13
Do medically unexplained symptoms matter? A prospective cohort study of 300 new referrals to neurology outpatient clinics. J Neurol Neurosurg Psychiatry (2000) 2.89
Automatic Monitoring of primary amines in preparative column effluents with fluorescamine. Anal Biochem (1975) 2.88
Analysis of receptive fields of cat retinal ganglion cells. J Neurophysiol (1965) 2.86
Effects at two years of a low-fat, high-carbohydrate diet on radiologic features of the breast: results from a randomized trial. Canadian Diet and Breast Cancer Prevention Study Group. J Natl Cancer Inst (1997) 2.46
Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J Neuropathol Exp Neurol (1997) 2.43
Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomarkers Prev (2001) 2.35
Case-control study of factors associated with failure to detect breast cancer by mammography. J Natl Cancer Inst (1992) 2.31
Sensitivity and specificity of first screen mammography in the Canadian National Breast Screening Study: a preliminary report from five centers. Radiology (1986) 2.30
Gallbladder contractility in patients with spinal cord injuries: a sonographic investigation. AJR Am J Roentgenol (1990) 2.24
Amino acid analysis with fluorescamine at the picomole level. Arch Biochem Biophys (1973) 2.23
Results of a quality assurance exercise for urinary glycosaminoglycan excretion. Ann Clin Biochem (1990) 2.21
Do basal cell carcinomas recur after complete conventional surgical excision? Br J Plast Surg (2005) 2.20
Pregnancy outcome at age 40 and older. Obstet Gynecol (1996) 2.09
Properties of cat retinal ganglion cells: a comparison of W-cells with X- and Y-cells. J Neurophysiol (1974) 2.08
Regulating complementary medicine. BMJ (1996) 2.07
Glutamate transporter protein subtypes are expressed differentially during rat CNS development. J Neurosci (1997) 2.01
LRRK2 mutations in Parkinson disease. Neurology (2005) 2.01
Symmetry of projection in the quantitative analysis of mammographic images. Eur J Cancer Prev (1996) 2.00
Conduction velocity of afferents to cat visual cortex: a correlation with cortical receptive field properties. Brain Res (1971) 1.92
Steady-state pharmacokinetics of indinavir in cerebrospinal fluid and plasma among adults with human immunodeficiency virus type 1 infection. Clin Pharmacol Ther (2000) 1.92
Relationship between astrocytes, ganglion cells and vasculature of the retina. J Comp Neurol (1987) 1.88
Hyperaccumulation of FAD-linked presenilin 1 variants in vivo. Nat Med (1997) 1.86
Mammographic density, lobular involution, and risk of breast cancer. Br J Cancer (2008) 1.83
Evidence for linkage on 21q and 7q in a subset of autism characterized by developmental regression. Mol Psychiatry (2005) 1.83
Response of cat retinal ganglion cells to moving visual patterns. J Neurophysiol (1965) 1.82
The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab (2001) 1.82
A quantitative analysis of the distribution of ganglion cells in the cat's retina. J Comp Neurol (1965) 1.82
Comparative evaluation of synaptophysin-based methods for quantification of synapses. J Neurocytol (1996) 1.80
Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention. Curr Oncol Rep (2001) 1.78
Vascular complications associated with spontaneous aortic dissection. J Vasc Surg (1988) 1.76
Impaired fatty acid oxidation in propofol infusion syndrome. Lancet (2001) 1.75
Automated analysis of mammographic densities. Phys Med Biol (1996) 1.74
The effect of oxygen on vasoformative cell division. Evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis. Invest Ophthalmol Vis Sci (1995) 1.73
Early Neurodegeneration after Hypoxia-Ischemia in Neonatal Rat Is Necrosis while Delayed Neuronal Death Is Apoptosis. Neurobiol Dis (2001) 1.72
Relay of receptive-field properties in dorsal lateral geniculate nucleus of the cat. J Neurophysiol (1972) 1.71
Dysfunctional beliefs and attitudes about sleep among older adults with and without insomnia complaints. Psychol Aging (1993) 1.70
Disability, distress and unemployment in neurology outpatients with symptoms 'unexplained by organic disease'. J Neurol Neurosurg Psychiatry (2011) 1.69
Contrast agent neurotoxicity presenting as subarachnoid hemorrhage. Neurology (1999) 1.67
Development of the human retinal vasculature: cellular relations and VEGF expression. Exp Eye Res (1997) 1.59
Biochemical characterization and localization of a non-N-methyl-D-aspartate glutamate receptor in rat brain. J Neurochem (1992) 1.58
Idiopathic recurrent pancreatitis. An approach to diagnosis and treatment. Dig Dis Sci (1989) 1.58
Projection of X- and Y-cells of the cat's lateral geniculate nucleus to areas 17 and 18 of visual cortex. J Neurophysiol (1973) 1.57
Excitotoxic neuronal death in the immature brain is an apoptosis-necrosis morphological continuum. J Comp Neurol (1997) 1.57
Naming of neurones. Classification and naming of cat retinal ganglion cells. Brain Behav Evol (1977) 1.51
Mammographic densities and breast cancer risk. Breast Dis (1998) 1.49
Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat. J Neurosci (2000) 1.49
Assessment of treatment for patients with primary ductal carcinoma in situ in the breast. Ann Surg Oncol (1998) 1.49
Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging. Neurobiol Aging (1996) 1.49
The treatment of Wilms' tumour with special reference to actinomycin D. Clin Radiol (1969) 1.49
The outcome of neurology outpatients with medically unexplained symptoms: a prospective cohort study. J Neurol Neurosurg Psychiatry (2003) 1.48
Dietary fat and breast cancer risk revisited: a meta-analysis of the published literature. Br J Cancer (2003) 1.48
Assessment of middle ear disease in the dog: a comparison of diagnostic imaging modalities. J Small Anim Pract (2007) 1.47
Limiting photoreceptor death and deconstruction during experimental retinal detachment: the value of oxygen supplementation. Am J Ophthalmol (1999) 1.47
Retinal distribution and central projections of Y-, X-, and W-cells of the cat's retina. J Neurophysiol (1974) 1.46
The impact of mitotic index on predicting outcome in breast carcinoma: a comparison of different counting methods in patients with different lymph node status. Mod Pathol (1991) 1.46
Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues. J Neurosci (1996) 1.44
Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol (1989) 1.42
The 2000 Canadian recommendations for the management of hypertension: Part one--therapy. Can J Cardiol (2001) 1.42
Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis. Liver Transpl Surg (1999) 1.41
Delayed neurodegeneration in neonatal rat thalamus after hypoxia-ischemia is apoptosis. J Neurosci (2001) 1.41
Summing properties of the cat's retinal ganglion cell. Vision Res (1968) 1.40
M11L: a novel mitochondria-localized protein of myxoma virus that blocks apoptosis of infected leukocytes. J Exp Med (2000) 1.39
Limiting the proliferation and reactivity of retinal Müller cells during experimental retinal detachment: the value of oxygen supplementation. Am J Ophthalmol (1999) 1.37
The association of middle ear effusion with trigeminal nerve mass lesions in dogs. Vet Rec (2013) 1.37
The outcome of depressive disorders in neurology patients: a prospective cohort study. J Neurol Neurosurg Psychiatry (2003) 1.36
Conduction velocity as a parameter in the organisation of the afferent relay in the cat's lateral geniculate nucleus. Brain Res (1971) 1.35
Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphologically distinct: further evidence for an apoptosis-necrosis continuum. J Comp Neurol (1997) 1.34
The effect of unilateral vagotomy on gastric secretion in the pylorus ligated rat. Proc Soc Exp Biol Med (1968) 1.33
The role of Müller cells in the formation of the blood-retinal barrier. Neuroscience (1993) 1.32
Helicopter transport of patients during acute myocardial infarction. Am J Cardiol (1988) 1.32
A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours. Br J Cancer (2011) 1.31
Serum beta 2 microglobulin and C-reactive protein in the monitoring of lymphomas: findings in a multicenter study and experience in selected patients. Cancer (1980) 1.31
Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. Blood (2001) 1.30
Mammographic signs as risk factors for breast cancer. Br J Cancer (1982) 1.28
The current status of multifetal pregnancy reduction. Am J Obstet Gynecol (1996) 1.27
The naso-temporal division of the monkey's retina. J Comp Neurol (1973) 1.26
Regional variation in nonmedical factors affecting family physicians' decisions about referral for consultation. CMAJ (1997) 1.26
Breast cancer risk and measured mammographic density. Eur J Cancer Prev (1998) 1.26
Epidemiology of infection due to Chlamydia trachomatis in Manitoba, Canada. Clin Infect Dis (1994) 1.24
Macronutrient intake and change in mammographic density at menopause: results from a randomized trial. Cancer Epidemiol Biomarkers Prev (1999) 1.24
Plasma lipids, lipoproteins, and mammographic densities. Cancer Epidemiol Biomarkers Prev (1996) 1.24